Bromide

Bromide

SCHEMBL3680180

CCCC[N+](CC)(CCCC)CCCC.[Br-]

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.69
DNM1 Q05193 5/20 0.68
TSHR P16473 2/20 0.61
ALDH1A1 P00352 1/20 0.61
TP53 P04637 1/20 0.61
CYP3A4 P08684 1/20 0.61
ALOX15 P16050 1/20 0.61
ALOX12 P18054 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HIF1A Q16665 1/20 0.61
HSD17B10 Q99714 1/20 0.61
SLC22A2 O15244 1/20 0.59
NFKB1 P19838 1/20 0.44
KCNA1 Q09470 1/20 0.44
HSP90AA1 P07900 1/20 0.43
RAD52 P43351 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL346989 0.97 SLC22A1 (0.73) SLC22A1DNM1TSHRALDH1A1TP53
Water SCHEMBL1332993 0.93 SLC22A1 (0.69) SLC22A1DNM1TSHRALDH1A1TP53
SCHEMBL10598482 0.93 SLC22A1 (0.69) SLC22A1DNM1TSHRALDH1A1TP53
Iodide SCHEMBL4333792 0.93 SLC22A1 (0.69) SLC22A1DNM1TSHRALDH1A1TP53
Bromide SCHEMBL2583511 0.93 SLC22A1 (0.69) SLC22A1DNM1TSHRALDH1A1TP53
SCHEMBL10598485 0.93 SLC22A1 (0.69) SLC22A1DNM1TSHRALDH1A1TP53
Hydrochloric Acid SCHEMBL5084823 0.93 SLC22A1 (0.69) SLC22A1DNM1TSHRALDH1A1TP53
Bromide SCHEMBL622840 0.93 DNM1 (0.78) SLC22A1DNM1TSHRALDH1A1TP53
Bromide SCHEMBL10697230 0.90 DNM1 (0.83) SLC22A1DNM1TSHRALDH1A1TP53
SCHEMBL11806867 0.90 DNM1 (0.78) SLC22A1DNM1TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023159094-A2 PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE PRAXIS PRECISION MEDICINES, INC. (US) 2023-08-24 WO claimed
CN-102309945-A Multi-component surfactant and preparation method thereof SHENZHEN MCT TECHNOLOGY CO LTD 2012-01-11 CN claimed
US-20060281926-A1 Synthesis of 2-alkylcysteine via phase transfer catalysis GIMI RAYOMAND H 2006-12-14 US claimed
US-4065601-A Two phase electrolytes used as halogen traps in metal halogen secondary cells and batteries ECO-CONTROL, INC. (US) 1977-12-27 US claimed
JP-55066531-A None JP disclosed
WO-2024004508-A1 METHOD FOR PRODUCING POLYSACCHARIDE FIBER 旭化成株式会社 2024-01-04 WO disclosed
WO-2023159094-A2 PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE PRAXIS PRECISION MEDICINES, INC. (US) 2023-08-24 WO disclosed
EP-1682609-B1 METHOD OF MODIFYING A FLUOROPOLYMER AND ARTICLES THEREBY 3M INNOVATIVE PROPERTIES CO (US) 2015-03-11 EP disclosed
CN-102309945-B Multi-component surfactant and preparation method thereof SHENZHEN MCT TECHNOLOGY CO LTD 2012-12-19 CN disclosed
CN-102309945-A Multi-component surfactant and preparation method thereof SHENZHEN MCT TECHNOLOGY CO LTD 2012-01-11 CN disclosed
EP-1814837-B1 A METHOD FOR PRODUCING 4,4,4-TRIFLUOROBUTANE-2-ONE CENTRAL GLASS CO LTD (JP) 2010-02-24 EP disclosed
EP-2014703-B1 Process of preparing a composite article 3M INNOVATIVE PROPERTIES CO (US) 2009-12-09 EP disclosed
EP-0268261-A1 Process for producing 1-hydrocarbyl mercaptans PHILLIPS PETROLEUM COMPANY (US) 1988-05-25 EP disclosed
EP-0004606-B1 PROCESS FOR PREPARING ANILINE COMPOUNDS ETHYL CORPORATION (US) 1982-03-10 EP disclosed
US-4267317-A CONCURRENT ETHERIFICATION AND DEHYDROGENATION OF A PHENOL BY REACTING WITH A 1-CARBOXY-3-HALOALKANE USING AN ALKALI METAL COMPOUND AND A SPECIAL SOLVENT IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 1981-05-12 US disclosed
US-4254262-A IN THE PRESENCE OF A QUATERNARY AMMONIUM OR PHOSPHONIUM SALT IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 1981-03-03 US disclosed
JP-S5566531-A PREPARATION OF PHENOXYALKENE DERIVATIVE IHARA CHEM IND CO LTD 1980-05-20 JP disclosed
US-4186147-A DISPLACEMENT OF THIOCYANOANILINE WITH AN ALCOHOL TO FORM THIOALKYL ANILINE ETHYL CORPORATION (US) 1980-01-29 US disclosed
EP-0004606-A2 Process for preparing aniline compounds ETHYL CORPORATION (US) 1979-10-17 EP disclosed
US-4022816-A TRIALKYL AMMONIUM OR PHOSPHONIUM CATALYST ETHYL CORPORATION (US) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281926-A1 Synthesis of 2-alkylcysteine via phase transfer catalysis DIMT1, ICMT, CNDP2 SLC22A1 1163/4885DNM1 1352/4885TSHR 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.